No photo of Raj Vuppalanchi

View Scopus Profile

Raj Vuppalanchi

  • 3982 Citations
  • 31 h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Raj Vuppalanchi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Chemical and Drug Induced Liver Injury Medicine & Life Sciences
Liver Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Fatty Liver Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Serum Medicine & Life Sciences
Morpholines Medicine & Life Sciences
Elasticity Imaging Techniques Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2005 2019

Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis

Mathur, K., Vuppalanchi, V., Gelow, K., Vuppalanchi, R. & Lammert, C., Jan 1 2019, In : Digestive Diseases and Sciences.

Research output: Contribution to journal › Article

Open Access
Cannabidiol
Autoimmune Hepatitis
Sleep
Pain
Fatigue

Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury

Ghabril, M., Gu, J., Yoder, L., Corbito, L., Ringel, A., Beyer, C. D., Vuppalanchi, R., Barnhart, H., Hayashi, P. H. & Chalasani, N., Nov 2019, In : Gastroenterology. 157, 5, p. 1245-1252.e3

Research output: Contribution to journal › Article

Chemical and Drug Induced Liver Injury
Comorbidity
Confidence Intervals
End Stage Liver Disease
Mortality
5 Citations (Scopus)

Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

NASH Clinical Research Network, Jan 1 2019, In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journal › Article

Fibrosis
Blood Platelets
Aspartate Aminotransferases
Biopsy
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)

Is Fasting Necessary for Individuals With Nonalcoholic Fatty Liver Disease to Undergo Vibration-Controlled Transient Elastography?

Vuppalanchi, R., Weber, R., Russell, S., Gawrieh, S., Samala, N., Slaven, J. E., Harden, L. & Chalasani, N., Jun 1 2019, In : The American journal of gastroenterology. 114, 6, p. 995-997 3 p.

Research output: Contribution to journal › Article

Elasticity Imaging Techniques
Vibration
Fasting
Meals
Liver
7 Citations (Scopus)

Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis

Vilar-Gomez, E., Vuppalanchi, R., Desai, A., Gawrieh, S., Ghabril, M., Saxena, R., Cummings, O. & Chalasani, N., Jan 1 2019, In : Alimentary Pharmacology and Therapeutics.

Research output: Contribution to journal › Article

Metformin
Fatty Liver
Fibrosis
Hepatocellular Carcinoma
Transplants